ArticleJournal of robotic surgery2025
Expanding the role of robotic surgery: Non-inferiority of robot-assisted radical cystectomy in overweight patients with bladder cancer.
Article in Journal of robotic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Kurt-Semm-Center of minimally invasive and robot-assisted surgery: Over 10 years of an interdisciplinary and interprofessional project in clinical application, research and training.Journal of robotic surgery · 2026Review
- Chronological and biological age stratify survival after robot-assisted radical cystectomy for bladder cancer: a pragmatic age-ECOG risk score.World journal of urology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundObesity is an increasing comorbidity in patients undergoing radical cystectomy. While robot-assisted radical cystectomy (RARC) has been widely adopted, evidence for its safety in overweight patients remains limited.
methodsWe retrospectively analyzed 337 consecutive patients who underwent RARC or open radical cystectomy (ORC) at a European tertiary center (2013–2024). Outcomes were stratified by body mass index (BMI) and assessed by regression and non-inferiority analyses.
resultsIn the presented cohort (135 normal-weight and 202 overweight patients) urinary-diversion patterns (continent vs. incontinent) did not differ by BMI or approach. RARC required longer operative times than ORC, but BMI itself had no independent effect. The length of stay (LOS) was shorter after RARC with BMI increasing LOS only in the ORC group. Adjusted models identified ORC as an independent predictor of prolonged stay. Non-inferiority of RARC in overweight patients was demonstrated for both length of stay (p = 0.044) and Clavien–Dindo-graded perioperative morbidity.
conclusionRARC delivers robust perioperative safety in overweight patients, maintaining non-inferiority for morbidity and LOS. These findings support the use of RARC as a standard approach to radical cystectomy, including in obese populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.